Explore tweets tagged as #ISPY2
【本日開催】 渋谷O-Crestにて 「MAGICAL SPEC 無銭ワンマン〜マジスペIDORISE!! FESTIVAL 2023感謝祭〜」 ⏰開場 16:30 / 開演 17:00 🎫無料(+1d) ※当日受付あり 「Weekday session〜 MAGICAL SPEC × iSPY2マンライブ 〜」 ⏰開場 19:00 / 開演 19:30 🎫当日券あり ※ANNAは前物販となります
1
14
65
本日はWeekday session〜MAGICAL SPEC × iSPY2マンライブ〜お越し頂きありがとうございました!✨ #マジスペ さん本日は2マンお呼び頂きありがとうございました❣️ これからも是非仲良くして下さい🥰 次のiSPYは3/16(木)19:15~【iSPY ×カメイドクロック無料定期公演】です!!🐢
0
2
55
#ASCO17 Merck's Keytruda passes test in ISPY2 neoadjuvant breast cancer study, high risk types
0
13
8
ISPY2.2 Dato-DXd+ durva, results of blocks A thru C: pCR 50% n=106 (n=42 HR+, n=64 TNBC) pCR 62% TNBC, 79% Immune + HR-HER2-Immune-DPD- :met graduation criteria @OncoAlert #ESMO24
1
11
23
ISPY2: THP + tucatinib with unacceptable g3-4 tox making it not feasible, unfortunately. @OncoAlert #bcsm #SABCS21
0
14
23
Weekday session〜MAGICAL SPEC × iSPY2マンライブ〜 ありがとうございました🫧 んー!楽しかったー!! マジスペさんとっても元気で可愛くて口角ずっと上がってた👼🏻♡ 呼んでいただきありがとうございます! またすぐ会えますように…✨ これからも仲良くしてください🫶🏻
10
13
123
Data from ispy2 shows IM lymphadenopathy in patients treated with neoadjuvant chemotherapy does not negatively impact outcome. #asbrs24 @ISPY2trial @DrMaraPiltin @MayoClinicSurg @MayoCancerCare
1
5
33
Ispy2 study shows Kadcyla + Perjeta better than taxol/Herceptin as neoadj therapy in Her2+ breast cancer @AACR
0
8
2
Every time I get to hear @DrLauraEsserman talk about #ISPY2 I wish even more we could just copy & paste for prostate cancer. This truly is a transformative framework, amazing work. @PCFnews #PCFRetreat
2
8
27
Great talk by Dr Rita Muktar on the treatment or breast cancer. Less is just as good as more from the ISpy2 data set. @UCSFSurgery
0
2
24
Breast conserving surgery has similar locoregional recurrence to mastectomy after neoadjuvant chemotherapy - excellent presentation from Dr Rita Mukhtar showing data from ISPY2 clinical trial @ISPY2trial #ASA2023
1
9
40
#asbs24 presentation by Kayla Switalla on the ISPY2 trial demonstrating increasing use of clip placement in patients with positive nodes. Data demonstrates that clip placement is beneficial and increases use of TAD @ISPY2trial
1
3
22
My latest blog @ecancer on the adaptive randomization and #ISPY2 trials. https://t.co/u1Boqwvi97.
@VincentRK @pash22
1
10
13
Is More Better? Customizing Systemic Therapy for High-Risk, Nonmetastatic Breast Cancer ➡️ Outstanding discussion 🔛 PEARLY trial, A-BRAVE trial and ISPY2.2 trial by @JavierCortesMD 👏🏻👏🏻👏🏻 #ASCO24 @OncoAlert #BreastCancer
0
7
12